Literature DB >> 2528023

[Increased atrial natriuretic peptide in essential hypertension--relation to right atrial pressure behavior].

L Neyses1, J Nitsch, H P Tüttenberg, H C Korus, B Lüderitz.   

Abstract

The role of atrial natriuretic peptide (ANP) in the pathogenesis of essential hypertension has not yet entirely been clarified. We investigated whether the increase of ANP in essential hypertension may be explained by elevated right atrial pressures and/or a different relationship between right atrial pressures and ANP secretion. Patients with stable essential hypertension undergoing right and left heart catheterization because of suspected coronary heart disease had significantly higher ANP levels than normotensives: 58.7 +/- 6.7 pg/ml in hypertensives versus 42.0 +/- 4.1 pg/ml in normotensives (p less than 0.01). Matching hypertensives with normotensives at identical levels of left ventricular enddiastolic pressure revealed significantly higher mean pulmonary artery pressures in hypertensives. Right atrial diastolic pressure (v-wave) after matching for LVEDP was 4.8 +/- 0.5 mm Hg in hypertensives and 3.1 +/- 0.2 mm Hg in normotensives (p less than 0.05). In addition, at any given mean right atrial pressure hypertensives showed higher ANP levels than normotensives. These results demonstrate that hypertensives exhibit raised pressures in the pulmonary artery independent of left ventricular pressure load. The elevation in right atrial pressures and the steeper relationship between these pressures and ANP are a suitable explanation for raised ANP levels in hypertension. ANP in essential hypertension may represent a counterregulation against elevated pulmonary resistance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2528023     DOI: 10.1007/bf01745345

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  18 in total

1.  Increased pulmonary vascular resistance with systemic hypertension. Effect of minoxidil and other antihypertensive agents.

Authors:  J M Atkins; H C Mitchell; W A Pettinger
Journal:  Am J Cardiol       Date:  1977-05-26       Impact factor: 2.778

2.  Correlates of plasma atrial natriuretic factor in health and hypertension.

Authors:  P Montorsi; G Tonolo; J Polonia; D Hepburn; A M Richards
Journal:  Hypertension       Date:  1987-12       Impact factor: 10.190

3.  Right ventricular performance in essential hypertension.

Authors:  J Ferlinz
Journal:  Circulation       Date:  1980-01       Impact factor: 29.690

4.  The heart in hypertension.

Authors:  R C Tarazi
Journal:  N Engl J Med       Date:  1985-01-31       Impact factor: 91.245

5.  Atrial natriuretic peptide and blood pressure in a geographically defined population.

Authors:  P Nilsson; L Lindholm; B Scherstén; R Horn; A Melander; R D Hesch
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

6.  [The atrial natriuretic factor in severe congestive heart failure. Plasma level, hemodynamic, hormonal and renal effects].

Authors:  A J Riegger; E P Kromer; K Kochsiek
Journal:  Dtsch Med Wochenschr       Date:  1985-10-18       Impact factor: 0.628

7.  Atrial natriuretic factor--a circulating hormone stimulated by volume loading.

Authors:  R E Lang; H Thölken; D Ganten; F C Luft; H Ruskoaho; T Unger
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

8.  Plasma concentration of human atrial natriuretic polypeptide in patients with impaired renal function.

Authors:  Y Yamamoto; T Higa; K Kitamura; K Tanaka; K Kangawa; H Matsuo
Journal:  Clin Nephrol       Date:  1987-02       Impact factor: 0.975

9.  Plasma levels of atrial natriuretic peptide are raised in essential hypertension during low and high sodium intake.

Authors:  G Wambach; S Götz; G Suckau; G Bönner; W Kaufmann
Journal:  Klin Wochenschr       Date:  1987-03-02

10.  Atrial natriuretic factor in plasma of patients with arterial hypertension, heart failure or cirrhosis of the liver.

Authors:  R M Arendt; A L Gerbes; D Ritter; E Stangl; P Bach; J Zähringer
Journal:  J Hypertens Suppl       Date:  1986-06
View more
  2 in total

1.  Human atrial natriuretic peptide in patients with type 1 diabetes mellitus: is it related to the development of diabetic nephropathy?

Authors:  E Jungmann; A Felber; S Graeber; U Hillmann; T Haak; K D Palitzsch; K H Usadel
Journal:  Clin Investig       Date:  1993-08

Review 2.  Renal long-term effects of calcium antagonist treatment in patients with diabetes mellitus.

Authors:  E Jungmann; K H Usadel
Journal:  Clin Investig       Date:  1992-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.